PMV Pharmaceuticals, Inc. stock is up 49.67% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 CALLs.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
03 Oct 14:29 | 19 Jan, 2024 | 12.50 | 2376 | ||
03 Oct 16:44 | 17 Nov, 2023 | 7.50 | 1571 |
PMV Pharmaceuticals, Inc. engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.